Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness

Cholangiocarcinoma (CCA) is the second most common primary liver malignancy with extremely poor therapeutic outcome due to high drug resistance, widespread metastasis and lack of effective treatment options. CCA progression and metastasis are regulated by multiple biological factors including multip...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Theranostics
Egile Nagusiak: Xie, Ying, Wang, Yazhe, Li, Jing, Hang, Yu, Jaramillo, Lee, Wehrkamp, Cody J., Phillippi, Mary Anne, Mohr, Ashley M., Chen, Yi, Talmon, Geoffrey A., Mott, Justin L., Oupický, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2018
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134930/
https://ncbi.nlm.nih.gov/pubmed/30214622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.26506
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak